Thomas Hucko

1.3k total citations · 1 hit paper
19 papers, 548 citations indexed

About

Thomas Hucko is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Thomas Hucko has authored 19 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Surgery. Recurrent topics in Thomas Hucko's work include Cardiac Imaging and Diagnostics (9 papers), Advanced MRI Techniques and Applications (8 papers) and Lipoproteins and Cardiovascular Health (6 papers). Thomas Hucko is often cited by papers focused on Cardiac Imaging and Diagnostics (9 papers), Advanced MRI Techniques and Applications (8 papers) and Lipoproteins and Cardiovascular Health (6 papers). Thomas Hucko collaborates with scholars based in Germany, Australia and United States. Thomas Hucko's co-authors include Steven E. Nissen, Rishi Puri, Yu Kataoka, Stephan Windecker, Giuseppe Di Giovanni, Julie Butters, Stephen Jones, Peter J. Psaltis, Stephen J. Nicholls and Huei Wang and has published in prestigious journals such as Journal of the American College of Cardiology, Radiology and Heart.

In The Last Decade

Thomas Hucko

18 papers receiving 540 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction

2022 243 citations Stephen J. Nicholls, Yu Kataoka et al. JACC. Cardiovascular imaging profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Hucko Germany	11	297	203	182	102	71	19	548
Stephen Jones Australia	6	265 0.9×	84 0.4×	84 0.5×	57 0.6×	67 0.9×	11	386
Neeraj Tandon United States	9	276 0.9×	307 1.5×	93 0.5×	35 0.3×	39 0.5×	20	548
Iftikhar Kullo United States	8	176 0.6×	145 0.7×	47 0.3×	35 0.3×	30 0.4×	20	374
Matthew Janik United States	13	401 1.4×	613 3.0×	289 1.6×	23 0.2×	37 0.5×	21	847
Hiroyuki Omori Japan	12	208 0.7×	127 0.6×	148 0.8×	22 0.2×	10 0.1×	29	357
Quanming Zhao China	11	122 0.4×	80 0.4×	35 0.2×	34 0.3×	23 0.3×	37	316
Raymond Henderson United Kingdom	8	125 0.4×	50 0.2×	21 0.1×	16 0.2×	71 1.0×	14	339
Anna Maria Ansaldo Italy	8	116 0.4×	161 0.8×	25 0.1×	43 0.4×	6 0.1×	10	304
Salman Waheed United States	9	39 0.1×	175 0.9×	32 0.2×	32 0.3×	8 0.1×	17	381
Anne‐Flore Plane France	6	52 0.2×	178 0.9×	50 0.3×	99 1.0×	4 0.1×	13	656

Countries citing papers authored by Thomas Hucko

Since Specialization

Citations

This map shows the geographic impact of Thomas Hucko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hucko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hucko more than expected).

Fields of papers citing papers by Thomas Hucko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Hucko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hucko. The network helps show where Thomas Hucko may publish in the future.

Co-authorship network of co-authors of Thomas Hucko

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Hucko. A scholar is included among the top collaborators of Thomas Hucko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Hucko. Thomas Hucko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Fujino, Masashi, Yu Kataoka, Julie Butters, et al.. (2025). Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis. European Journal of Preventive Cardiology. 1 indexed citations

Fujino, Masashi, Giuseppe Di Giovanni, Yu Kataoka, et al.. (2025). Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENS. Atherosclerosis. 403. 119145–119145. 2 indexed citations

Nicholls, Stephen J., Yu Kataoka, Steven E. Nissen, et al.. (2022). Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction. JACC. Cardiovascular imaging. 15(7). 1308–1321. 243 indexed citations breakdown →

Nicholls, Stephen J., Steven E. Nissen, Francesco Prati, et al.. (2021). Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study. Cardiovascular Diagnosis and Therapy. 11(1). 120–129. 51 indexed citations

Felker, G. Michael, Scott D. Solomon, Brian Claggett, et al.. (2021). Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure. JAMA Cardiology. 7(1). 26–26. 61 indexed citations

Koren, Michael J., Peter H. Jones, Jennifer G. Robinson, et al.. (2020). A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 Studies. Cardiology and Therapy. 9(2). 447–465. 7 indexed citations

Nicholls, Stephen J., Christie M. Ballantyne, Leslie Cho, et al.. (2020). EFFECT OF LONGER-TERM ADMINISTRATION OF EVOLOCUMAB IN PATIENTS WITH ANGIOGRAPHIC CORONARY ARTERY DISEASE: RESULTS OF THE GLAGOV OPEN LABELLED EXTENSION STUDY. Journal of the American College of Cardiology. 75(11). 1869–1869. 2 indexed citations

Dietrich, Thore, Dietmar Berndorff, Tobias Heinrich, et al.. (2015). Targeted ED-B fibronectin SPECT in vivo imaging in experimental atherosclerosis.. PubMed. 59(2). 228–37. 4 indexed citations

Manka, Robert, Cosima Jahnke, Thomas Hucko, et al.. (2013). Reproducibility of small animal cine and scar cardiac magnetic resonance imaging using a clinical 3.0 tesla system. BMC Medical Imaging. 13(1). 44–44. 2 indexed citations

10.

Hucko, Thomas, Christoph Klein, Bernhard Schnackenburg, et al.. (2013). Cardiovascular magnetic resonance stress perfusion imaging in patients with atrial fibrillation. Journal of Cardiovascular Magnetic Resonance. 15. E59–E59.

11.

Schneeweis, Christopher, Tomas Lapinskas, Bernhard Schnackenburg, et al.. (2013). Comparison of myocardial tagging and feature tracking in patients with severe aortic stenosis. Journal of Cardiovascular Magnetic Resonance. 15(4). P100–P100. 14 indexed citations

12.

Gebker, Rolf, Cosima Jahnke, Robert Manka, et al.. (2011). High spatial resolution myocardial perfusion imaging during high dose dobutamine/atropine stress magnetic resonance using k–t SENSE. International Journal of Cardiology. 158(3). 411–416. 14 indexed citations

13.

Gebker, Rolf, Cosima Jahnke, Robert Manka, et al.. (2011). The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease. Journal of Cardiovascular Magnetic Resonance. 13(1). 46–46. 15 indexed citations

14.

Dietrich, Thore, Thomas Hucko, Andreas Menrad, et al.. (2011). Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells. Atherosclerosis. 220(2). 329–336. 58 indexed citations

15.

Messroghli, Daniel, Sarah Nordmeyer, Martin Buehrer, et al.. (2011). Small Animal Look-Locker Inversion Recovery (SALLI) for Simultaneous Generation of Cardiac T1 Maps and Cine and Inversion Recovery–prepared Images at High Heart Rates: Initial Experience. Radiology. 261(1). 258–265. 21 indexed citations

16.

Gebker, Rolf, Jesús G. Mirelis, Cosima Jahnke, et al.. (2010). Influence of left ventricular hypertrophy and geometry on diagnostic accuracy of wall motion and perfusion analysis during dobutamine stress magnetic resonance. Journal of Cardiovascular Magnetic Resonance. 12(S1). 1 indexed citations

17.

Gebker, Rolf, Jesús G. Mirelis, Cosima Jahnke, et al.. (2010). Influence of Left Ventricular Hypertrophy and Geometry on Diagnostic Accuracy of Wall Motion and Perfusion Magnetic Resonance During Dobutamine Stress. Circulation Cardiovascular Imaging. 3(5). 507–514. 17 indexed citations

18.

Dietrich, Thore, Thomas Hucko, Riad Bourayou, et al.. (2009). High resolution magnetic resonance imaging in atherosclerotic mice treated with ezetimibe. International journal of cardiac imaging. 25(8). 827–836. 15 indexed citations

19.

Gebker, Rolf, Cosima Jahnke, Thomas Hucko, et al.. (2009). Dobutamine stress magnetic resonance imaging for the detection of coronary artery disease in women. Heart. 96(8). 616–620. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact